Mayflower Financial Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1852930 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$790,130

-$64,486 QoQ

Shares Held

6,254

+2.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#1,178

of 2,266 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. GILD ranks #9 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	101,672	$25,584,742
2	BMY	Bristol Myers Squibb Co	208,112	$11,991,413
3	JNJ	Johnson & Johnson	24,544	$6,233,439
4	LLY	ELI LILLY & Co	3,906	$4,684,973
5	MRK	Merck & Co., Inc.	20,163	$2,590,945
6	PFE	Pfizer Inc	58,088	$1,398,759
7	NVS	Novartis AG	8,591	$1,346,381
8	AMGN	Amgen Inc	3,665	$1,327,169

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$790,130	6,254	+2.0%	Shares	Sole	2026-07-09
2026-03-31	$854,616	6,132	+41.9%	Shares	Sole	2026-04-23
2025-12-31	$530,482	4,322	+10.4%	Shares	Sole	2026-01-13
2025-09-30	$434,454	3,914	+8.3%	Shares	Sole	2025-10-17
2025-06-30	$400,573	3,613	-1.7%	Shares	Sole	2025-08-04
2025-03-31	$411,895	3,676	+7.3%	Shares	Sole	2025-05-02
2024-12-31	$316,551	3,427	-28.1%	Shares	Sole	2025-01-22
2022-09-30	$294,076	4,767	+1.6%	Shares	Sole	2022-10-19
2022-06-30	$290,136	4,694	-1.2%	Shares	Sole	2022-07-15
2022-03-31	$282,506	4,752	-15.6%	Shares	Sole	2022-04-21
2021-12-31	$408,794	5,630	+1.3%	Shares	Sole	2022-01-21
2021-09-30	$388,086	5,556	-8.0%	Shares	Sole	2021-10-26
2021-06-30	$415,776	6,038	+0.0%	Shares	Sole	2021-07-29
2021-03-31	$390,042	6,035	-0.1%	Shares	Sole	2021-04-23
2020-12-31	$351,948	6,041	—	Shares	Sole	2021-04-12
No filing history on record for this holder in this stock.